Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02124421
Title Outcomes in CRS/HIPEC as Initial Treatment of Ovarian, Fallopian Tube and Primary Peritoneal Cancer
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Mercy Medical Center

ovarian cancer

fallopian tube cancer

peritoneum cancer


Carboplatin + Paclitaxel

Cisplatin + Paclitaxel

Age Groups: adult
Covered Countries USA

No variant requirements are available.